Table of contents
As pharma companies approach commercial launch, supply chain complexity increases—and so does the risk. Manual communication, scattered spreadsheets, and disjointed processes often lead to inefficiencies, excess inventory, and delayed decision-making at the worst possible time.
Peter Bigelow, CEO of SCmple, explains how his company helps early-stage pharma organizations improve planning and operational execution. As a TraceLink technology partner, SCmple works closely with companies preparing for launch, providing a lightweight planning platform that complements TraceLink’s MINT solution. Together, these tools give supply chain teams the visibility and integration they need to improve collaboration with suppliers and eliminate costly manual work.
Key Takeaways:
- Manual processes and disconnected tools make it difficult for early-stage companies to manage supply chain risk.
- SCmple helps companies deploy cost-effective planning tools without the burden of large ERP implementations.
- TraceLink’s MINT enables more accurate, real-time communication with suppliers—helping eliminate errors and excess inventory.
Watch the full interview to learn how SCmple and TraceLink are helping emerging pharma companies modernize their supply chains.
Video Highlights:
01:26 - Why is it getting harder to manage risk in today's pharmaceutical supply chain?
02:50 - What advice do you have for companies navigating these challenges as they move from clinical to commercial?
04:19 - What makes your partnership with TraceLink—and solutions like MINT—valuable to your work with clients?
05:27 - What's one critical challenge that TraceLink MINT helps address for supply chain teams?
